SEK 0.57
(4.63%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 3.6 Million SEK | 2.86% |
2022 | 3.5 Million SEK | 0.0% |
2021 | - SEK | 0.0% |
2020 | - SEK | 0.0% |
2019 | - SEK | -100.0% |
2018 | 2.99 Million SEK | -40.2% |
2017 | 5 Million SEK | 0.0% |
2016 | - SEK | 0.0% |
2015 | - SEK | 0.0% |
2014 | - SEK | 0.0% |
2013 | - SEK | -100.0% |
2012 | 5000.00 SEK | -94.51% |
2011 | 91 Thousand SEK | -73.78% |
2010 | 347 Thousand SEK | -33.01% |
2009 | 518 Thousand SEK | 106.37% |
2008 | 251 Thousand SEK | -98.34% |
2007 | 15.11 Million SEK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - SEK | 0.0% |
2024 Q1 | 5.9 Million SEK | -100.0% |
2023 Q4 | 3.6 Million SEK | -48.57% |
2023 Q3 | 7 Million SEK | -4.11% |
2023 Q2 | 7.3 Million SEK | -3.95% |
2023 Q1 | 7.6 Million SEK | 117.14% |
2023 FY | 3.6 Million SEK | 2.86% |
2022 Q1 | 1.4 Million SEK | 0.0% |
2022 FY | 3.5 Million SEK | 0.0% |
2022 Q3 | 1.3 Million SEK | -7.14% |
2022 Q4 | 3.5 Million SEK | 169.23% |
2022 Q2 | 1.4 Million SEK | 0.0% |
2021 Q2 | 100 Thousand SEK | 0.0% |
2021 FY | - SEK | 0.0% |
2021 Q3 | - SEK | -100.0% |
2021 Q4 | - SEK | 0.0% |
2021 Q1 | - SEK | 0.0% |
2020 Q4 | - SEK | 0.0% |
2020 Q3 | - SEK | 0.0% |
2020 Q2 | - SEK | 0.0% |
2020 Q1 | - SEK | 0.0% |
2020 FY | - SEK | 0.0% |
2019 Q3 | - SEK | 0.0% |
2019 Q4 | - SEK | 0.0% |
2019 FY | - SEK | -100.0% |
2019 Q1 | 2.5 Million SEK | -16.39% |
2019 Q2 | - SEK | -100.0% |
2018 Q3 | - SEK | 0.0% |
2018 Q4 | 2.99 Million SEK | 0.0% |
2018 Q2 | - SEK | 0.0% |
2018 FY | 2.99 Million SEK | -40.2% |
2018 Q1 | - SEK | -100.0% |
2017 Q2 | - SEK | 0.0% |
2017 Q1 | - SEK | 0.0% |
2017 FY | 5 Million SEK | 0.0% |
2017 Q3 | - SEK | 0.0% |
2017 Q4 | 5 Million SEK | 0.0% |
2016 Q3 | - SEK | 0.0% |
2016 FY | - SEK | 0.0% |
2016 Q4 | - SEK | 0.0% |
2016 Q2 | - SEK | 0.0% |
2016 Q1 | - SEK | 0.0% |
2015 FY | - SEK | 0.0% |
2015 Q3 | - SEK | 0.0% |
2015 Q2 | - SEK | 0.0% |
2015 Q1 | - SEK | 0.0% |
2015 Q4 | - SEK | 0.0% |
2014 FY | - SEK | 0.0% |
2014 Q4 | - SEK | 0.0% |
2014 Q3 | - SEK | 0.0% |
2014 Q2 | - SEK | 0.0% |
2014 Q1 | - SEK | 0.0% |
2013 Q4 | - SEK | 0.0% |
2013 Q3 | - SEK | 0.0% |
2013 FY | - SEK | -100.0% |
2013 Q2 | - SEK | 0.0% |
2012 Q4 | 5000.00 SEK | 0.0% |
2012 FY | 5000.00 SEK | -94.51% |
2011 FY | 91 Thousand SEK | -73.78% |
2010 FY | 347 Thousand SEK | -33.01% |
2009 FY | 518 Thousand SEK | 106.37% |
2008 FY | 251 Thousand SEK | -98.34% |
2007 FY | 15.11 Million SEK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
AddLife AB (publ) | 2.53 Billion SEK | 99.858% |
Biotage AB (publ) | 150 Million SEK | 97.6% |
Bonesupport Holding AB (publ) | 13.22 Million SEK | 72.773% |
Elekta AB (publ) | 4.8 Billion SEK | 99.925% |
iZafe Group AB (publ) | 279 Thousand SEK | -1190.323% |
Ortivus AB (publ) | 3.57 Million SEK | -0.727% |
Ortivus AB (publ) | 3.57 Million SEK | -0.727% |
Q-linea AB (publ) | 12.9 Million SEK | 72.104% |
S2Medical AB (publ) | - SEK | -Infinity% |
Synsam AB (publ) | 2.02 Billion SEK | 99.823% |